Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoë Fuchs

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Medicine|April 20, 2022
Strategies for inclusive grantmakingMaryrose Franko, Sindy Escobar-Alvarez, Zoë Fuchs, et al.
Therapeutic Advances in Rare Disease|July 29, 2024
The role of the TSC Alliance in advancing therapy development: a patient organization perspectiveSteven L Roberds, Zoë Fuchs, Elizabeth M Cassidy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 2, 2016
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapyKathryn M Camacho, Stefano Menegatti, Douglas R Vogus, et al.
Epilepsia|April 14, 2026
The small molecule simufilam dose-dependently attenuates the worsening of seizures in a mouse model of tuberous sclerosis complexBranden Stansley, Md Monirul Islam, Dean J Aguiar, et al.
Pediatric Neurology|August 16, 2021
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management RecommendationsHope Northrup, Mary E Aronow, E Martina Bebin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Medicine|April 20, 2022
Strategies for inclusive grantmakingMaryrose Franko, Sindy Escobar-Alvarez, Zoë Fuchs, et al.
Therapeutic Advances in Rare Disease|July 29, 2024
The role of the TSC Alliance in advancing therapy development: a patient organization perspectiveSteven L Roberds, Zoë Fuchs, Elizabeth M Cassidy, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 2, 2016
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapyKathryn M Camacho, Stefano Menegatti, Douglas R Vogus, et al.
Epilepsia|April 14, 2026
The small molecule simufilam dose-dependently attenuates the worsening of seizures in a mouse model of tuberous sclerosis complexBranden Stansley, Md Monirul Islam, Dean J Aguiar, et al.
Pediatric Neurology|August 16, 2021
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management RecommendationsHope Northrup, Mary E Aronow, E Martina Bebin, et al.
Pageof 1